Integration of clinical and T-cell immune profiling to predict early response to CD3xBCMA bispecific antibody immunotherapy in Multiple Myeloma
Nicolas Deredec, Lisa Aziez, Ismaël Boussaid, Justine Decroocq, Axel Guedon, Margaux Michot, Cyril Catelain, Dorothée Selimoglu‐Buet, Ahmadreza Arbab, Cécile Alanio, Olivier Kosmider, Lise Willems, Michaëla Fontenay, Patricia Franchi, Rudy Birsen, , Yannick Simoni
This study integrates clinical and T-cell immune profiling to identify early biomarkers of response to CD3xBCMA bispecific antibody therapy in multiple myeloma.
bioRxiv · Aug 21, 2026 · PreprintImmunology